Furthermore, our study has demonstrated a novel regulatory pathway of SMAD3 in NSCLC cells, namely the SMAD3/ITGA6/PI3K/Akt signaling pathway, as illustrated in Fig. 10. Here, ITGA6 is linked to non-small cell lung carcinoma.